Pinto Bernardine M, Kindred Madison, Dunsiger Shira, Mitchell Sheryl, Patel Ashwin, Ostendorf Danielle, Huebschmann Amy G
College of Nursing, University of South Carolina, 1601 Greene Street, Room 302B, Columbia, SC, 29208, USA.
Department of Kinesiology, Augusta University, Augusta, GA, USA.
J Cancer Surviv. 2025 May 27. doi: 10.1007/s11764-025-01811-7.
We previously demonstrated that a 3-month peer-delivered program (Moving Forward Together, MFT) significantly increased breast cancer survivors' moderate-to-vigorous PA (MVPA). To enhance MFT's scalability and reach, we adapted it to an existing web platform and developed webMFT. Our goal was to test the efficacy of webMFT on survivors' MVPA.
In a randomized controlled trial, we trained ten peer coaches from cancer care organizations to deliver webMFT or MVPA Tracking to 61 breast cancer survivors (mean age = 58.10 years [SD = 8.55], 1.40 years post-diagnosis [SD = 0.50], 80% Stage 0-1 cancer) for 3 months. Both groups received a FitBit® tracker and behavioral supports of weekly synchronization reminders, physical activity (PA) tipsheets, and recommended PA goals. In addition, webMFT participants received weekly coaching calls tailored to their FitBit® data shared through the web platform. All participants wore an Actigraph accelerometer for 7 days at baseline and at post-intervention and completed quality of life (QOL), mood, fatigue and physical functioning questionnaires. We used mixed effects regression models to examine between-group differences on outcomes.
Both groups significantly increased their MVPA from baseline to 12 weeks but there were no significant between-group differences in change in MVPA (b = - 22.84, SE = 16.99, p = .18). There were significant between-group effects favoring webMFT in improved QOL at 12 weeks (b = 1.56, SE = 0.77, p = .04).
Adapting the efficacious MFT intervention for web delivery did not result in significant improvements in MVPA vs. MVPA Tracking. This raises questions as to whether the efforts undertaken to adapt and deliver the program through the web platform were justified as compared to MVPA Tracking with behavioral supports.
Promoting PA does not require web delivery of coaching-using physical activity trackers with weekly reminders and resources is also effective.
This trial was registered in Clinicaltrials.gov on 6/8/2022 (NCT05409664).
我们之前证明了一项为期3个月的同伴主导计划（共同前进，MFT）显著增加了乳腺癌幸存者的中等到剧烈身体活动（MVPA）。为了提高MFT的可扩展性和覆盖面，我们将其改编为一个现有的网络平台，并开发了网络MFT。我们的目标是测试网络MFT对幸存者MVPA的疗效。
在一项随机对照试验中，我们培训了来自癌症护理组织的10名同伴教练，为61名乳腺癌幸存者（平均年龄 = 58.10岁[标准差 = 8.55]，诊断后1.40年[标准差 = 0.50]，80%为0-1期癌症）提供网络MFT或MVPA追踪服务，为期3个月。两组都收到了一个FitBit®追踪器以及每周同步提醒、身体活动（PA）小贴士和推荐PA目标的行为支持。此外，网络MFT参与者还收到根据他们通过网络平台分享的FitBit®数据量身定制的每周辅导电话。所有参与者在基线和干预后佩戴Actigraph加速度计7天，并完成生活质量（QOL）、情绪、疲劳和身体功能问卷。我们使用混合效应回归模型来检查组间在结果上的差异。
两组从基线到12周MVPA均显著增加，但MVPA变化的组间差异不显著（b = -22.84，标准误 = 16.99，p = 0.18）。在12周时，组间效应显著有利于网络MFT改善生活质量（b = 1.56，标准误 = 0.77，p = 0.04）。
将有效的MFT干预改编为网络交付与MVPA追踪相比，并未导致MVPA有显著改善。这就提出了一个问题，即与带有行为支持的MVPA追踪相比，通过网络平台改编和交付该计划所做的努力是否合理。
促进身体活动并不需要通过网络提供辅导——使用带有每周提醒和资源的身体活动追踪器也有效。
该试验于2022年6月8日在Clinicaltrials.gov上注册（NCT05409664）。
